Location: Home
  • search
  • go
  • Relate News
  • 12/13/2019BeiGene Announces Clinical Data on Anti-PD-1 Tislelizumab in Combo wit...
  • 12/13/2019Here's What's In, What's Out of U.S.-China Trade Deal
  • 12/13/2019ZJ Medicine and Ambrx Present Positive Data from a Phase 1a/1b Trial o...
  • 12/13/2019Granules to Dispose Full Stake in Chinese JV
  • 12/13/2019NMPA and NHC Issues Joint Notice for Vaccine IT Tracing Infrastructura...
  • 12/13/2019Preview of 16 Heavy-weight New Drug Expected to be Approved in China N...
  • 12/13/2019IQVIA: Chinese Hospital Drug Market Up 9.7% in MAT Q3/2019
  • 12/13/2019IQVIA: Chinese Retail Pharmacy Sales Up 1.9% in Q3/2019
  • 12/12/2019ChP Commission Solicits Comments on the draft of “Naming Principles f...
  • 12/12/2019Eli Lilly's Verzenio and Amgen's Blincyto To Be Granted Priority Revie...
  • 12/12/2019Upcoming Event: International Conference on Biosimilars and Biologics
  • 12/12/2019Astrazeneca Rounds Out Stellar China Year - And Beats Roche To The Pun...
  • 12/12/2019Numab and 3SBio's Subsidiary Form Partnership to Develop Novel Multi-s...
  • 12/12/2019NMPA Issues the Guidelines for Aluminum Adjuvant in Preventative Vacci...
  • 12/12/2019AstraZeneca Granted Chinese Approval of Imfinziin for Unresectable Sta...
  • 12/11/2019Avantor Opens Center in Shanghai to Boost Biopharma Innovation in Chin...
  • 12/11/2019China's Cancer Patients Hit by New Law on Experimental Drug Treatments...
  • 12/11/2019Harbin Pharmaceutical Group Poised to Take Over Ailing GNC
  • 12/11/2019Private Investigator Couple Sue GSK for Misleading Work in China
  • 12/10/2019National Drug Usage Monitoring Platform Becomes Operational
  • 12/10/2019SAMR Solicits Public Comments on the Provisions for Registration of Dr...
  • 12/10/2019CStone's anti-PD-L1 antibody Demonstrates Promising Antitumor Activity
  • 12/10/2019China Cuts Prices For 70 More Drugs After Talks with Pharmaceutical Fi...
  • 12/9/2019PingAn Good Doctor and Merck Sign Agreement to Explore Integrated Heal...
  • 12/9/2019Samsung Bioepis Approved to Initiate Phase 3 Trial of Trastuzumab Bios...
  • 12/9/2019Joinn Bio Raises $60M in Round A Financing
  • 12/6/2019NHSA Issues New Policy for Drug Price Regulation
  • 12/6/2019Recent Executive Moves
  • 12/6/2019Innovent Announces First Patient Dosed in Phase I Trial of Anti-LAG-3 ...
  • 12/5/2019Amgen's IND for Osteoporosis Drug Romosozumab Approved in China
  • Page:255/774 Total number of articles:23208: [First][<<] [253] [254] [255] [256] [257] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group